Cancer therapy monitoring in xenografts by quantitative analysis of circulating tumor DNA.

  • Tobias Gorges
  • Johanna Schiller
  • Arndt Schmitz
  • Daniel Schuetzmann
  • Christoph Schatz
  • Thomas M Zollner
  • Thomas Krahn
  • Oliver von Ahsen

Related Research units

Abstract

Circulating tumor DNA (ctDNA) is a promising biomarker in cancer.

Bibliographical data

Original languageEnglish
Article number6
ISSN1354-750X
Publication statusPublished - 2012
pubmed 22616911